EU expands Wegovy, Ozempic probe over suicide risks to include other weight loss, diabetes drugs

The European Medicines Agency didn't specify which additional GLP-1 drugs are now being investigated, but it could potentially include Eli Lilly's Mounjaro.

from Health and Science https://ift.tt/B9ukxEc
https://ift.tt/nVD8NTL
https://ift.tt/RGmvEbz